BeOne Medicines Ltd. (6160)
6160 · Health Care · 
China
BeOne Medicines Ltd. (6160) is a Chinese company in the Health Care sector. The stock has its largest weight in XCS6 (MSCI China), at 1.00%. Anyone who holds an ETF containing BeOne Medicines also has an indirect stake in the company.
Data and Charts: BeOne Medicines
Key Data for BeOne Medicines
Alysly Data Analysis: BeOne Medicines
What ETF Is BeOne Medicines In?
BeOne Medicines has average ETF coverage and is held by 10 of the 104 ETFs we track, which together follow 5 indices. That puts the stock in more ETFs than 63.8% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XCS6 / XCS7 | MSCI China | 1.00% | €10.04 |
| SPYM | MSCI Emerging Markets | 0.21% | €2.08 |
| XMME / XEMD | MSCI Emerging Markets | 0.20% | €1.95 |
| IS3N | MSCI EM IMI | 0.17% | €1.70 |
| SPYY | MSCI ACWI | 0.02% | €0.22 |
| IUSQ | MSCI ACWI | 0.02% | €0.20 |
| SPYI / SPSA | MSCI ACWI IMI | 0.01% | €0.06 |
The last column shows how much of €1,000 in one of these funds goes to BeOne Medicines, based on each fund's latest holdings list.
US-listed ETFs holding BeOne Medicines (weight per latest SEC filing): VXUS 0.05%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
What's Inside Your ETF Portfolio and the ETF overlap check show how much BeOne Medicines overlaps with the rest of a portfolio.
Stocks With ETF Exposure Similar to BeOne Medicines
| Stock | Shared ETFs | r |
|---|---|---|
| BeOne Medicines | – | – |
| CSPC Pharmaceutical Group Limited | 10 | – |
| Sinopharm Group | 10 | – |
| 3SBio | 10 | – |
| XtalPi Holdings Limited | 10 | – |
| Sichuan Kelun-Biotech Biopharmaceutical | 10 | – |
| Akeso | 10 | – |
| RemeGen | 10 | – |
| Legend Biotech Corp. Sponsored | 10 | – |
These stocks reach a portfolio through largely the same funds as BeOne Medicines. “Shared ETFs” counts the funds that hold both.
